(Q48348434)

10 February 2018

title

Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo. (English)

1 reference

10 February 2018

main subject

long-term potentiation

1 reference

V V Trubetskaya

1

1 reference

10 February 2018

M Yu Stepanichev

2

1 reference

10 February 2018

M V Onufriev

3

1 reference

10 February 2018

N A Lazareva

4

1 reference

10 February 2018

V A Markevich

5

1 reference

10 February 2018

N V Gulyaeva

6

1 reference

10 February 2018

publication date

1 February 2003

1 reference

10 February 2018

Neuroscience and Behavioral Physiology

published in

1 reference

10 February 2018

volume

33

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

95-98

1 reference

10 February 2018

In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat.

cites work

1 reference

12 December 2020

Cholinergic facilitation and inhibition of long-term potentiation of CA1 in the urethane-anaesthetized rats.

1 reference

12 December 2020

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

1 reference

12 December 2020

beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus.

1 reference

12 December 2020

Intrahippocampal injections of exogenous beta-amyloid induce postdelay errors in an eight-arm radial maze.

1 reference

12 December 2020

beta-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro

1 reference

12 December 2020

Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides

1 reference

12 December 2020

Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity

1 reference

12 December 2020

Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments.

1 reference

12 December 2020

[Effect of intracerebroventricular administration of the (25-35) fragment of beta-amyloid peptide on the lipid peroxidation level in rat brain structures and blood]

1 reference

12 December 2020

Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons.

1 reference

12 December 2020

Reactive oxygen species and nitric oxide mediate plasticity of neuronal calcium signaling.

1 reference

12 December 2020

Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.

1 reference

12 December 2020

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

12 December 2020

Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease

1 reference

12 December 2020

[The effect of the administration of beta-amyloid peptide fragment (25-35) on behavior in rats].

1 reference

12 December 2020

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

12 December 2020

Beta-amyloid induced reduction in synaptic transmission is reversed by inhibitors of nitric oxide synthase

1 reference

12 December 2020

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

1 reference

12 December 2020

Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1021761310435

1 reference

10 February 2018

PubMed ID

12669778

1 reference

10 February 2018